Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Neurofibromatosis 1 × Radiation × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Prostatic Neoplasms 47 Glioblastoma 46 Breast Neoplasms 39 Esophageal Neoplasms 36 Rectal Neoplasms 34 Carcinoma, Non-Small-Cell Lung 33 Lung Neoplasms 32 Head and Neck Neoplasms 29 Squamous Cell Carcinoma of Head and Neck 26 Pancreatic Neoplasms 22 Brain Neoplasms 22 Neoplasms 19 Uterine Cervical Neoplasms 17 Oropharyngeal Neoplasms 16 Neoplasm Metastasis 16 Esophageal Squamous Cell Carcinoma 16 Gliosarcoma 15 Glioma 15 Sarcoma 14 Melanoma 14 Stomach Neoplasms 12 Adenocarcinoma Of Esophagus 12 Lymphoma, Follicular 9 Carcinoma, Squamous Cell 9 Mouth Neoplasms 8 Lymphoma, B-Cell, Marginal Zone 8 Anus Neoplasms 8 Precursor Cell Lymphoblastic Leukemia-Lymphoma 7 Leukemia, Myeloid, Acute 7 Endometrial Neoplasms 7

Interventions

AZD 6244 9 Lovastatin 5 Deoxycholic Acid 4 trametinib 3 Lasers, Solid-State 3 mirdametinib 2 fludarabine 2 Transcranial Direct Current Stimulation 2 Sirolimus 2 Polidocanol 2 Magnetic Resonance Imaging 2 Lasers 2 Lamotrigine 2 Inhalation 2 Acetylcysteine 2 thymoglobulin 1 talimogene laherparepvec 1 peginterferon alfa-2b 1 gadolinium compound P760 1 fludarabine phosphate 1 diphenylcyclopropenone 1 cabozantinib 1 binimetinib 1 X-Rays 1 Vitamin D 1 Vincristine 1 Vinblastine 1 Temozolomide 1 Surgical Procedures, Operative 1 Sunitinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07521657 2026-04-13

NF118

University of Alabama at Birmingham

Phase 2 Not yet recruiting

Glioblastoma, Glioma, Neurofibromatosis 1

Data powered by HemOnc (CC BY 4.0) Colophon ⚡